Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-06 | New | $19,000,000 | $19,000,000 | Equity Only | 06b | SEC link |
| 2022-05-25 | Amended | $19,420,000 | $14,070,000 | Equity Only | 06b | SEC link |
| 2021-12-09 | Amended | $5,350,000 | $4,850,000 | Equity Only | 06b | SEC link |
| 2021-09-14 | Amended | $500,000 | $0 | Equity Only | SEC link | |
| 2021-08-20 | New | $500,000 | $500,000 | Equity Only | 06c | SEC link |
| Name | Role |
|---|---|
| Oray Boston, Jr. | Director |
| Henry Brem | Director |
| H Brett Friedman | Director |
| Brett Friedman | Director |
| Chad Gordon | Director |
| Steven Klasko | Director |
| Michael Maglin | Executive |
| Brian Moran | Director |
| Joshua Scheinker | Director |
| Elliot Stone | Director |
| Deborah I Weidman | Executive |
| Sharon Wolfington | Director |